Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy
- PMID: 24004884
- DOI: 10.1016/j.jconrel.2013.08.022
Spatial-temporal event adaptive characteristics of nanocarrier drug delivery in cancer therapy
Abstract
In cancer therapy, drug delivery is a complex process that aims to transit the cargo to the destination with as little damage to the normal tissue as possible. In the last decade, tremendous development and research on nanomedicine have been exploring an ideal system with efficient drug transportation and release property. For this end, series of barriers need to be circumvented by nanomedicine, including systemic barriers, such as biosurface adsorption, phagocytic clearance, bloodstream washing, interstitial pressure, degradation, as well as intracellular barriers, such as cell membrane reorganization and internalization, endo/lysosomal escape, cytosolic or subcellular localization. Rather than being random, these barriers follow a specific spatial-temporal sequence. Therefore, the nanocarriers have to be endowed with characteristics that are adaptive to particular biological milieu on systemic and intracellular levels. To this end, we reviewed the correlations between the spatial-temporal sequences of drug delivery and nanocarrier characteristics in cancer therapy, as well as strategies to achieve efficient drug delivery upon both systemic and intracellular levels.
Keywords: Drug delivery; Intracellular targeting; Spatial–temporal sequence; Stimuli-responsive; Systemic targeting.
© 2013.
Similar articles
-
Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.J Biomed Mater Res A. 2017 Oct;105(10):2906-2928. doi: 10.1002/jbm.a.36141. Epub 2017 Jul 14. J Biomed Mater Res A. 2017. PMID: 28643475 Review.
-
How are we applying nanogel composites in biomedicine?Nanomedicine (Lond). 2017 Jul;12(14):1627-1630. doi: 10.2217/nnm-2017-0152. Epub 2017 Jun 21. Nanomedicine (Lond). 2017. PMID: 28635377 No abstract available.
-
Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.Arch Pharm Res. 2018 Feb;41(2):111-129. doi: 10.1007/s12272-017-0995-x. Epub 2017 Dec 6. Arch Pharm Res. 2018. PMID: 29214601 Review.
-
A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.Biomaterials. 2015 Oct;65:43-55. doi: 10.1016/j.biomaterials.2015.06.042. Epub 2015 Jun 24. Biomaterials. 2015. PMID: 26142775
-
Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review.J Control Release. 2017 Jul 28;258:226-253. doi: 10.1016/j.jconrel.2017.04.043. Epub 2017 May 2. J Control Release. 2017. PMID: 28472638 Review.
Cited by
-
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles.J Cell Mol Med. 2017 Sep;21(9):1668-1686. doi: 10.1111/jcmm.13110. Epub 2017 Feb 28. J Cell Mol Med. 2017. PMID: 28244656 Free PMC article. Review.
-
Insight into nanoparticle cellular uptake and intracellular targeting.J Control Release. 2014 Sep 28;190:485-99. doi: 10.1016/j.jconrel.2014.06.038. Epub 2014 Jun 28. J Control Release. 2014. PMID: 24984011 Free PMC article. Review.
-
Application of chitosan-based nanocarriers in tumor-targeted drug delivery.Mol Biotechnol. 2015 Mar;57(3):201-18. doi: 10.1007/s12033-014-9816-3. Mol Biotechnol. 2015. PMID: 25385004 Review.
-
In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.Int J Nanomedicine. 2020 Sep 23;15:7035-7049. doi: 10.2147/IJN.S255902. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33061366 Free PMC article.
-
PEG4000 modified liposomes enhance the solubility of quercetin and improve the liposome functionality: in vitro characterization and the cellular efficacy.Turk J Chem. 2022 Feb 23;46(4):1011-1023. doi: 10.55730/1300-0527.3411. eCollection 2022. Turk J Chem. 2022. PMID: 37538767 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
